Fachklinik Bad Bentheim

The Fachklinik Bad Bentheim conducts research in skin and connective tissue diseases, focusing on chronic venous ulcer to evaluate a new topical agent that aims to speed wound closure while ensuring safety.

• Topical dose‑response assessment
• Placebo‑controlled efficacy measurement
• Monitoring of adverse events
• Patient‑reported wound healing outcomes

This work at the Bad Bentheim site seeks to provide faster, safer healing options for patients with therapy‑resistant ulcers.

In the area of skin and connective tissue diseases, the clinic investigates prurigo nodularis using an investigational monoclonal antibody designed to reduce severe itching and improve quality of life.

• Double‑blind efficacy evaluation
• Numeric rating scale for itch intensity
• Open‑label safety extension phase
• Assessment of patient‑reported symptom relief

The study at Fachklinik Bad Bentheim aims to deliver a novel therapeutic option for individuals struggling with persistent pruritic skin lesions.